Keyphrases
Multiple Sclerosis
85%
Experimental Autoimmune Encephalomyelitis
81%
Experimental Stroke
77%
WIN55,212-2
46%
Transient Middle Cerebral Artery Occlusion (tMCAO)
44%
T Cells
44%
Neuroprotection
42%
Hypothermia
39%
Cerebral Ischemia
37%
Drug-induced Hypothermia
36%
Disease Severity
31%
Axonal Degeneration
31%
Cannabinoids
28%
Neuroprotective
28%
Macrophages
28%
Immunomodulatory Effect
25%
Leukocyte Infiltration
25%
Calpain
25%
Mixed Lineage Kinase
22%
Immunomodulation
22%
Calpain Activity
22%
First Relapse
22%
Survival Time
20%
Kinase Inhibitor
19%
Microglia
19%
Inflammatory Cytokines
19%
Rat Hippocampus
19%
Ischemia
18%
In Vivo Conditions
17%
Neuroinflammation
17%
Ischemic Heart Disease
17%
Protozoa
17%
Selectivity Studies
17%
Statin Therapy
17%
Infarct
17%
Western World
17%
Chemokine Production
17%
Damage Production
17%
RhoA
17%
Neuronal Death
17%
T Cell Activation
17%
Pimonidazole
17%
Edema
17%
Endoplasmic Reticulum Stress (ER stress)
17%
S-groups
17%
Toxicity Study
17%
Spatial Assessment
17%
Necrosis-like
17%
Postsynaptic Density Protein 95 (PSD-95)
17%
Temporal Features
17%
Neuroscience
Cerebrovascular Accident
100%
Multiple Sclerosis
67%
Experimental Autoimmune Encephalomyelitis
60%
T Cell
58%
Hypothermia
45%
Middle Cerebral Artery
44%
Brain Ischemia
44%
Neuroprotection
42%
Cannabinoid
37%
Nerve Fiber Degeneration
37%
Axonal Degeneration
37%
Macrophage
32%
Neuroprotective Agent
29%
Ischemia
25%
Cell Infiltration
23%
Mixed Lineage Kinase
22%
Calpain
22%
Leukocyte
22%
Programmed Cell Death
20%
Cell Death
20%
Hippocampus
18%
Proinflammatory Cytokine
18%
Agonist
17%
Ipsapirone
17%
Glycan
17%
Neuronal Cell Death
17%
Endoplasmic Reticulum Stress
17%
CHOP
17%
Necrosis
17%
Disks Large Homolog 4
17%
Statin
17%
5-HT1A Receptor
17%
Oligodendrocyte
17%
Dexamethasone
17%
Cell Activation
17%
Chemokine
17%
Microglia
15%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
88%
Experimental Autoimmune Encephalomyelitis
58%
Experimental Stroke
56%
Cerebrovascular Accident
54%
Diseases
42%
Middle Cerebral Artery Occlusion
32%
Infarction
31%
Disease Severity
30%
Survival Time
20%
Nerve Fiber Degeneration
19%
Neuroprotection
19%
Neuroprotective Agent
19%
Inflammation
18%
Calpain
17%
Nervous System Inflammation
17%
Dexamethasone
17%
Lipopolysaccharide
17%
Chemokine
17%
Necrosis
17%
Biological Marker
17%
Ipsapirone
17%
Edema
17%
Trichuris suis
17%
Hypothermia
17%
Serotonin 1A Receptor
17%
Disks Large Homolog 4
17%
Glycan
17%
Experimental Mouse
17%
Protozoon
17%
Helminth
17%
Ischemia
15%
